» Articles » PMID: 37013457

A Structure Activity Relationship Study of 3,4'-dimethoxyflavone for ArlRS Inhibition in

Abstract

Infections caused by methicillin-resistant (MRSA) are difficult to treat due to their resistance to many β-lactam antibiotics, and their highly coordinated excretion of virulence factors. One way in which MRSA accomplishes this is by responding to environmental stimuli using two-component systems (TCS). The ArlRS TCS has been identified as having a key role in regulating virulence in both systemic and local infections caused by . We recently disclosed 3,4'-dimethoxyflavone as a selective ArlRS inhibitor. In this study we explore the structure-activity relationship (SAR) of the flavone scaffold for ArlRS inhibition and identify several compounds with increased activity compared to the parent. Additionally, we identify a compound that suppresses oxacillin resistance in MRSA, and begin to probe the mechanism of action behind this activity.

Citing Articles

Structure-Photoreactivity Relationship Study of Substituted 3-Hydroxyflavones and 3-Hydroxyflavothiones for Improving Carbon Monoxide Photorelease.

Jezequel Y, Sverak F, Ramundo A, Orel V, Martinek M, Klan P J Org Chem. 2024; 89(7):4888-4903.

PMID: 38517741 PMC: 11002828. DOI: 10.1021/acs.joc.4c00070.

References
1.
Powers M, Bubeck Wardenburg J . Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis. PLoS Pathog. 2014; 10(2):e1003871. PMC: 3923759. DOI: 10.1371/journal.ppat.1003871. View

2.
Cha J, Vakulenko S, Mobashery S . Characterization of the beta-lactam antibiotic sensor domain of the MecR1 signal sensor/transducer protein from methicillin-resistant Staphylococcus aureus. Biochemistry. 2007; 46(26):7822-31. DOI: 10.1021/bi7005459. View

3.
Rasmussen T, Givskov M . Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol. 2006; 296(2-3):149-61. DOI: 10.1016/j.ijmm.2006.02.005. View

4.
Dastgheyb S, Parvizi J, Shapiro I, Hickok N, Otto M . Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis. 2014; 211(4):641-50. PMC: 4318921. DOI: 10.1093/infdis/jiu514. View

5.
Jacobsson G, Nasic S . Long-term outcome of invasive Staphylococcus aureus infections. Scand J Infect Dis. 2011; 44(5):350-4. DOI: 10.3109/00365548.2011.641504. View